$3250 | Single User
$6500 | Site License
$9750 | Enterprise License

AIDS Related Kaposi's Sarcoma -Epidemiology Forecast to 2027
[Report Updated: 14-02-2018]

Published by Delve Insight: 14 Feb 2018 | 201599 | In Stock

Introduction

DelveInsight's "AIDS Related Kaposi's Sarcoma - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the AIDS Related Kaposi's Sarcoma epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered

• United States

• EU5 (Germany, France, Italy, Spain, and the United Kingdom)

• Japan

Study Period: 2016-2027

AIDS Related Kaposi's Sarcoma Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for AIDS Related Kaposi's Sarcoma in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the AIDS Related Kaposi's Sarcoma outlook. It also includes the explanation of changing trends of epidemiology outlining the AIDS Related Kaposi's Sarcoma scenario.

AIDS Related Kaposi's Sarcoma Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the AIDS Related Kaposi's Sarcoma thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

• The report covers detailed overview of AIDS Related Kaposi's Sarcoma explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

• The AIDS Related Kaposi's Sarcoma Report assesses the disease risk and burden and highlights the unmet needs

• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

• 10 Year Forecast

• 7MM Coverage

• Total Cases in AIDS Related Kaposi's Sarcoma

Key assessments

• Patient Segmentation in AIDS Related Kaposi's Sarcoma

• AIDS Related Kaposi's Sarcoma Risk & Burden

• Factors driving growth in a specific AIDS Related Kaposi's Sarcoma patient population

Table of Contents
for AIDS Related Kaposi's Sarcoma -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

  • 1. Report Introduction

    2. AIDS Related Kaposi's Sarcoma Epidemiology Overview at a Glance

    2.1. Patient Share Distribution of AIDS Related Kaposi's Sarcoma in 2017

    2.2. Patient Share Distribution of AIDS Related Kaposi's Sarcoma in 2027

    3. Disease Background and Overview: AIDS Related Kaposi's Sarcoma

    3.1. Introduction

    3.2. Symptoms

    3.3. Etiology

    3.4. Risk Factors

    3.5. Pathophysiology

    3.6. Diagnosis

    3.7. Treatment

    4. Epidemiology and Patient Population

    4.1. Key Findings

    4.2. Total Prevalent/ Incident Patient Population of AIDS Related Kaposi's Sarcoma in 7MM

    4.3. Total Prevalent/ Incident Patient Population of AIDS Related Kaposi's Sarcoma in 7MM – By Countries

    5. Epidemiology of AIDS Related Kaposi's Sarcoma by Countries

    5.1. United States

    5.1.1. Assumptions and Rationale

    5.1.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma

    5.1.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma *

    5.1.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*

    5.1.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma

    5.2. EU5

    5.3. Assumptions and Rationale

    5.4. Germany

    5.4.1. Assumptions and Rationale

    5.4.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma

    5.4.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*

    5.4.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*

    5.4.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma

    5.5. France

    5.5.1. Assumptions and Rationale

    5.5.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma

    5.5.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*

    5.5.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*

    5.5.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma

    5.6. Italy

    5.6.1. Assumptions and Rationale

    5.6.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma

    5.6.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*

    5.6.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*

    5.6.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma

    5.7. Spain

    5.7.1. Assumptions and Rationale

    5.7.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma

    5.7.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*

    5.7.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*

    5.7.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma

    5.8. United Kingdom

    5.8.1. Assumptions and Rationale

    5.8.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma

    5.8.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*

    5.8.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*

    5.8.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma

    5.9. Japan

    5.9.1. Assumptions and Rationale

    5.9.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma

    5.9.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*

    5.9.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*

    5.9.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma

    6. Unmet Needs of the AIDS Related Kaposi's Sarcoma

    7. Appendix

    8. Report Methodology

    8.1. Sources

    9. DelveInsight Capabilities

    10. Disclaimer

    11. About DelveInsight

    *Indication Specific

List Of Tables
in AIDS Related Kaposi's Sarcoma -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Table 1: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM

Table 2: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM by Countries

Table 3: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)

Table 4: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)*

Table 5: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)*

Table 6: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)

Table 7: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027)

Table 8: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027) *

Table 9: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027) *

Table 10: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027)

Table 11: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027)

Table 12: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027) *

Table 13: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027) *

Table 14: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027)

Table 15: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027)

Table 16: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027) *

Table 17: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027) *

Table 18: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027)

Table 19: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027)

Table 20: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027) *

Table 21: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027) *

Table 22: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027)

Table 23: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027)

Table 24: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027) *

Table 25: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027) *

Table 26: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027)

Table 27: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027)

Table 28: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027) *

Table 29: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027) *

Table 30: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027)

List Of Figures, Charts and Diagrams
in AIDS Related Kaposi's Sarcoma -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Table 1: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM

Table 2: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM by Countries

Table 3: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)

Table 4: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)*

Table 5: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)*

Table 6: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2027)

Table 7: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027)

Table 8: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027) *

Table 9: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027) *

Table 10: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2027)

Table 11: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027)

Table 12: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027) *

Table 13: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027) *

Table 14: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2027)

Table 15: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027)

Table 16: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027) *

Table 17: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027) *

Table 18: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2027)

Table 19: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027)

Table 20: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027) *

Table 21: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027) *

Table 22: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2027)

Table 23: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027)

Table 24: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027) *

Table 25: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027) *

Table 26: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2027)

Table 27: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027)

Table 28: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027) *

Table 29: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027) *

Table 30: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2027)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

201599 | DIEI0249

Number of Pages

50

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global AIDS Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
International AIDS Vaccine Initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInternational AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that focuses on...
27 Apr 2016 by Global Data USD $250 More Info
International AIDS Vaccine Initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInternational AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that focuses on...
14 Mar 2016 by Global Data USD $250 More Info
United States Mobility Aids and Transportation Equipment Market Outlook to 2021
United States Mobility Aids and Transportation Equipment Market Outlook to 2021SummaryGlobalData’s n...
14 Mar 2016 by Global Data USD $2,500 More Info
United Kingdom Mobility Aids and Transportation Equipment Market Outlook to 2021
United Kingdom Mobility Aids and Transportation Equipment Market Outlook to 2021SummaryGlobalData’s ...
14 Mar 2016 by Global Data USD $2,500 More Info
France Mobility Aids and Transportation Equipment Market Outlook to 2021
France Mobility Aids and Transportation Equipment Market Outlook to 2021SummaryGlobalData’s new repo...
14 Mar 2016 by Global Data USD $2,500 More Info
Germany Mobility Aids and Transportation Equipment Market Outlook to 2021
Germany Mobility Aids and Transportation Equipment Market Outlook to 2021SummaryGlobalData’s new rep...
14 Mar 2016 by Global Data USD $2,500 More Info
Italy Mobility Aids and Transportation Equipment Market Outlook to 2021
Italy Mobility Aids and Transportation Equipment Market Outlook to 2021SummaryGlobalData’s new repor...
14 Mar 2016 by Global Data USD $2,500 More Info
Spain Mobility Aids and Transportation Equipment Market Outlook to 2021
Spain Mobility Aids and Transportation Equipment Market Outlook to 2021SummaryGlobalData’s new repor...
14 Mar 2016 by Global Data USD $2,500 More Info
Mobility Aids and Transportation Equipment - Medical Devices Pipeline Assessment, 2016
Mobility Aids and Transportation Equipment - Medical Devices Pipeline Assessment, 2016SummaryGlobalD...
11 Mar 2016 by Global Data USD $2,500 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

AIDS Related Kaposi's Sarcoma -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...